Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BEAM THERAPEUTICS INC.(BEAM) | 0 | 5,443,039 | +5,443,039 | 0 | 127,530 | 47.94% | +127,530 |
| RAPPORT THERAPEUTICS, INC.(RAPP) | 0 | 3,728,738 | +3,728,738 | 0 | 86,730 | 32.60% | +86,730 |
| ERASCA, INC.(ERAS) | 11,055,554 | 11,055,554 | 0 | 22,774 | 26,091 | 9.81% | +3,317 |
| SINGULAR GENOMICS SYSTEMS, INC. | 0 | 126,630 | +126,630 | 0 | 1,070 | 0.40% | +1,070 |
| Q32 BIO INC.(FIXX) | 320,482 | 320,482 | 0 | 5,461 | 5,753 | 2.16% | +292 |
| UNITY BIOTECHNOLOGY, INC. | 1,004,817 | 1,004,817 | 0 | 1,648 | 1,357 | 0.51% | -291 |
| SINGULAR GENOMICS SYSTEMS, INC. | 3,798,926 | 0 | -3,798,926 | 1,953 | 0 | — | -1,953 |
| GOSSAMER BIO, INC.(GOSS) | 8,055,916 | 8,055,916 | 0 | 9,506 | 7,258 | 2.73% | -2,248 |
| CERO THERAPEUTICS HOLDINGS, INC.(CERO) | 1,444,296 | 1,444,296 | 0 | 4,434 | 432 | 0.16% | -4,002 |
| DENALI THERAPEUTICS, INC.(DNLI) | 381,249 | 0 | -381,249 | 7,823 | 0 | — | -7,823 |
| VERVE THERAPEUTICS, INC. | 2,008,809 | 2,008,809 | 0 | 26,677 | 9,803 | 3.69% | -16,874 |